2016
DOI: 10.1016/j.bjane.2013.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Anesthesia in a patient with Stiff Person Syndrome

Abstract: Stiff Person Syndrome (SPS), typified by rigidity in muscles of the torso and extremities and painful episodic spasms, is a rare autoimmune-based neurological disease. Here we present the successful endotracheal intubation and application of TIVA without muscle relaxants on an SPS patient. A 46 years old male patient was operated with ASA-II physical status because of lumber vertebral compression fracture. After induction of anesthesia using lidocaine, propofol and remifentanil tracheal intubation was complete… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 11 publications
0
5
0
Order By: Relevance
“…[10][11][12] since then, many more reports have demonstrated safe use of various anesthetic agents and techniques in SPS patients. Use of volatile anesthetics, muscle relaxants, regional anesthetics, and total intravenous anesthesia (TIVA) with propofol have all been described in the literature for SPS patients without complication [13][14][15][16][17][18]. Our patient received sevoflurane, rocuronium, and sugammadex along with judicious amounts of benzodiazepine, opioid and dexmedetomidine without postoperative complications.…”
Section: Discussionmentioning
confidence: 95%
“…[10][11][12] since then, many more reports have demonstrated safe use of various anesthetic agents and techniques in SPS patients. Use of volatile anesthetics, muscle relaxants, regional anesthetics, and total intravenous anesthesia (TIVA) with propofol have all been described in the literature for SPS patients without complication [13][14][15][16][17][18]. Our patient received sevoflurane, rocuronium, and sugammadex along with judicious amounts of benzodiazepine, opioid and dexmedetomidine without postoperative complications.…”
Section: Discussionmentioning
confidence: 95%
“…The estimated prevalence of SPS is 1 of 1000,000 2 ; therefore, there are few reports on the general anesthetic management of patients with SPS. 3–5 The pathophysiology of SPS involves GAD, an enzyme essential for GABA synthesis. 6 Furthermore, SPS has been reported to be caused by atrophic Renshaw cells.…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that prolonged weakness after general anesthesia may be a result of enhanced central GABAergic transmission due to the interaction between the volatile agent and commonly used medication for SPS, such as baclofen. 4 Additionally, a patient who was anesthetized with total intravenous anesthesia, including propofol showed postoperative hypotonia, despite recovery from muscle relaxant on train-of-four monitoring. 8 Remimazolam has several advantages in patients with SPS.…”
Section: Discussionmentioning
confidence: 99%
“…Due to extremely low incidence of the disease, limited data is available on the anesthetic management of patient with SPS. 6 We used spinal anesthesia (bupivacaine and fentanyl) for total hip replacement because general anesthesia might have been associated with delayed emergence and recovery. This technique provides suitable condition for the surgery.…”
Section: Discussionmentioning
confidence: 99%